New Indications definition

New Indications means an additional indication of the medicinal product which was approved by SIDC after the original registration of the medicinal product.
Sample 1Sample 2Sample 3
New Indications means any indication for the Product other than the Initial Indications, which is subject to Takeda’s right of first refusal as provided in Section 3.2.
Sample 1Sample 2
New Indications has the meaning set forth in Section 4.02(c).
Sample 1Sample 2

Examples of New Indications in a sentence

  • New indications about the pole orientation and the shape parameters for 241 Germania are presented and a synodicperiod is estimated for 509 Iolanda.

  • New indications for mineralisation should be followed up, probably by a programme, of satellite photograph examination and, then, by prospecting the areas of interest on the ground.

  • New indications and reformulations are frequently used R&D strategies to extend a drug‘s lifecycle.

  • Operational personnel will be able to familiarise/train with the New indications.

  • The development or revision of a CMP most commonly occurs because of the following: • Emerging and/or availability of new healthcare diagnostic and therapeutic technologies, pharmaceuticals, medical devices, and medical/surgical/behavioral health services and procedures;• New indications or contraindications pertaining to existing healthcare diagnostic and therapeutic technologies, pharmaceuticals, medical devices, and medical/surgical/behavioral health services and procedures.


More Definitions of New Indications

New Indications means any indication outside the Field (excluding Autoimmune Indications, Stem Cell Transplantation and Transplantation Indications).
Sample 1Sample 2
New Indications means clinical indications, uses and applications for the Product other than what is included in the Field.
Sample 1Sample 2
New Indications means any indication of a disease state other than the Indications, that is developed as part of the Joint Development Program (excluding diagnosis).
Sample 1
New Indications means any indication for the Product other than the Initial Indications, which is subject to Takeda’s right of first refusal as provided in Section 3.2. “Party” or “Parties” shall have the meaning set forth in the introductory paragraph. “Phase IV Studies” shall mean clinical studies performed after obtaining Marketing Authorization for the purpose of supporting the marketing and Commercialization of the Product. For the avoidance of any doubt, “Phase IV Studies” does not include the RRS (as hereinafter defined). “Post-Marketing Surveillance” shall mean all post-marketing safety surveillance in the Initial Territory with respect to the Product that is required by a Regulatory Authority in the Initial Territory or any Additional Territory in which the Products are being Developed or Commercialized. “Primary Detail Equivalent” or “PDE” shall mean (a) one Primary Product Detail or (b) [**] Secondary Product Details.
Sample 1
New Indications means any topical indication for the Compound, Products or Subject Technology being proposed for addition to the Work Plan.
Sample 1
New Indications means, with respect to any Product, any Indication (other than the Initial Indications) approved by the JSC pursuant to Sections ‎3.1(a) and ‎3.4 in which such Product may be Developed, Manufactured and Commercialized under this Agreement.
Sample 1
New Indications means any indication outside the Field (excluding hyperuricemia and gout).
Sample 1